Home / News

New insights into how cancer spreads prompt rethink of metastasis care

A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads.

A clinical study of ovarian and colorectal cancer patients found cancer cells move in the bloodstream in clusters more commonly than was previously thought. The discovery could help doctors more quickly identify which cancer patients are at high risk of having their cancer spread to other organs, knowledge that could guide treatment decisions. The findings also potentially open new avenues for treatment.

Classified as: Faculty of Medicine and Health Sciences, dermatology, David Juncker, cancer research, metastases
Category:
Published on: 5 May 2025

Made-to-order diagnostic tests may be on the horizon

McGill University researchers have made a breakthrough in diagnostic technology, inventing a ‘lab on a chip’ that can be 3D-printed in just 30 minutes. The chip has the potential to make on-the-spot testing widely accessible.  

Classified as: mcgill research, David Juncker, Department of Biomedical Engineering, diagnostic tools, 3D print, testing
Category:
Published on: 29 Nov 2023

McGill University and Moderna to expand collaborations with new projects in Lipid Nanoparticle research

McGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs). LNPs are critical components in mRNA medicines such as vaccines, as they are the primary delivery method of mRNA strands to the target cells.

Classified as: mrna, Moderna, David Juncker, Julia Burnier, RI-MUHC, Gerald Bronfman Department of Oncology
Category:
Published on: 19 Jul 2023

Experts: Random COVID-19 testing resumes at four major airports

Mandatory random COVID-19 testing resumed on Tuesday, July 19 for vaccinated travellers coming into Canada through four major airports. The tests for select passengers landing in Toronto, Vancouver, Calgary and Montreal will be completed outside the airports, either through an in-person appointment or a virtual appointment for a self-swab test. (Toronto Star)

Classified as: McGill experts, covid-19, COVID-19 pandemic, pandemic, air travel, testing, David Juncker, Department of Biomedical Engineering, michael libman, Department of Medicine, Division of Infectious Diseases
Category:
Published on: 19 Jul 2022

A sweet solution to hard brain implants

Study uses sugar to make and deliver pudding-like brain implants that reduce foreign body response

Brain implants are used to treat neurological dysfunction, and their use for enhancing cognitive abilities is a promising field of research. Implants can be used to monitor brain activity or stimulate parts of the brain using electrical pulses. In epilepsy, for example, brain implants can determine where in the brain seizures are happening.

Classified as: Neuro, MNI, brain implants, Tim Kennedy, David Juncker, Edward Zhang
Category:
Published on: 4 May 2021

New technology can detect hundreds of proteins in a single sample

New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.

Proteins found in blood provide scientists and clinicians with key information on our health. These biological markers can determine if a chest pain is caused by a cardiac event or if a patient has cancer.

Classified as: David Juncker, Milad Dagher, fluorescent dyes, protein analysis, algorithm, nplex biosciences
Category:
Published on: 13 Aug 2018
Back to top